<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04856722</url>
  </required_header>
  <id_info>
    <org_study_id>Uro_Azhar_11_021</org_study_id>
    <nct_id>NCT04856722</nct_id>
  </id_info>
  <brief_title>Mini- Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery, and Extracorporeal Shock Wave Lithotripsy for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones</brief_title>
  <official_title>Mini- Percutaneous Nephrolithotomy (mPNL), Retrograde Intrarenal Surgery (RIRS), and Extracorporeal Shock Wave Lithotripsy (SWL) for Treatment of Medium-Sized, High-Density, Non-Lower Pole, Renal Stones: A Prospective, Randomized, Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Al-Azhar University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Al-Azhar University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal management of medium-sized renal stones remains quite challenging and continues&#xD;
      to be contested. In the present study, the investigators will compare mini-PNL, RIRS and SWL&#xD;
      in the treatment of non- lower pole, medium size, high dense renal stones regarding the&#xD;
      stone-free rate, the safety of the procedures, cost, and patients' and surgeon's&#xD;
      satisfaction. Eligible patients will be randomly allocated into three equal groups (mini-PNL,&#xD;
      RIRS, and SWL). Postoperative, patients will be followed-up by regularly for 3 months. The&#xD;
      study parameters will be compared between groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment options for renal stones 10-20 mm include either extracorporeal shock wave&#xD;
      lithotripsy (SWL) or endourology (retrograde intrarenal surgery (RIRS) and percutaneous&#xD;
      nephrolithotomy (PNL).&#xD;
&#xD;
      SWL is an attractive treatment option for renal stones because it is non-invasive and more&#xD;
      acceptable for the patient and can be done under analgesia, sedation, or minimal anaesthesia.&#xD;
      However, the limitation of SWL includes a relatively lower stone-free rate (SFR) and the need&#xD;
      for repeated sessions and auxiliary procedures. The SFR after SWL is affected by several&#xD;
      factors, including body mass index (BMI), stone size, intrarenal stone location,&#xD;
      skin-to-stone distance (SSD), and stone density.&#xD;
&#xD;
      The EAU guidelines put endourology and SWL as two equal options in medium-sized non-lower&#xD;
      pole renal stones and did not give special attention to the stone density, which is an&#xD;
      important predictor for SWL outcome. Several studies reported that the number of SWL sessions&#xD;
      increased with increased stone attenuation value (SAV) and SFR decreased significantly in&#xD;
      high-density renal stone.&#xD;
&#xD;
      PNL and RIRS have good SFR compared to SWL but might entail a significant risk of morbidity.&#xD;
      The improved fURS instrumentation and lithotripsy technology, and development of the&#xD;
      miniaturized PNL technique, may lower the procedure-related complications and mPNL and RIRS&#xD;
      an alternative and excellent option for medium-sized and even large renal stones The&#xD;
      investigators hypothesize that addressing the stone density factor may give a clear&#xD;
      recommendation for medium-sized, high-density renal stones. They expected the superiority for&#xD;
      either mPNL or RIRS, regarding SFR, without increased morbidity.&#xD;
&#xD;
      The study aims to compare the outcome of mPNL, RIRS, and SWL for treatment of non-lower pole,&#xD;
      high-density renal stones of 10 to 20 mm size.&#xD;
&#xD;
      The study will include adult patients with non-lower pole, high-density (&gt;1000 HU) renal&#xD;
      stones of 10 to 20 mm size.&#xD;
&#xD;
      Pre-operatively, patients will be evaluated by medical history taking, physical examination.&#xD;
      urinalysis, urine culture, complete blood cell count (CBC), liver function tests, coagulation&#xD;
      profile, blood urea nitrogen (BUN), serum creatinine, plain abdominal X-ray and computed&#xD;
      tomography for urinary tract (CT-UT), Eligible patients will be randomly divided into 3 equal&#xD;
      groups. PNL group, in which PNL procedures will be performed using miniature nephroscope,&#xD;
      RIRS group, in which RIRS will be performed using flexible ureteroscope and SWL group, in&#xD;
      which SWL procedures will be performed using Dornier Lithotripter.&#xD;
&#xD;
      post-operatively, patients will be followed up regularly, for 3 months. The SFR, complication&#xD;
      rate, cost, patients' and surgeon's satisfaction will be evaluated and compared between the&#xD;
      three groups using the appropriate statistical tests and analytical program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone-free rate</measure>
    <time_frame>as detected by non-contrasted computed tomography 3 months after the intervention procedures.</time_frame>
    <description>Stone free status is defined as no residual renal stone or residual fragment(s) less than 4 mm size.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication rate</measure>
    <time_frame>up to 3 months.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost of treatment</measure>
    <time_frame>throughout the study procedure, up to 3 months post-operative.</time_frame>
    <description>The cost of each treatment methods will be estimated, Including the devices, disposable instruments, operating room, bed stay, imaging, laboratory, medications, retreatment and ancillary procedures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients satisfaction</measure>
    <time_frame>throughout the study procedure, up to 3 months post-operative</time_frame>
    <description>A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon's satisfaction.</measure>
    <time_frame>throughout the study procedure, up to 3 months post-operative</time_frame>
    <description>A 5-point scale will be used to assess satisfaction, where 1 is unsatisfied and 5 fully satisfied.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Renal Stone</condition>
  <condition>Percutaneous Nephrolithotomy</condition>
  <condition>Retrograde Intrarenal Surgery</condition>
  <condition>Extracorporeal Shockwave Lithotripsy</condition>
  <arm_group>
    <arm_group_label>mini-PNL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In which PCNL will be performed using miniature nephroscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RIRS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In which RIRS will be performed using a flexible ureteroscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SWL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In which extracorporeal shock wave lithotripsy will be performed using Dornier lithotripter SII</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>mini-PNL</intervention_name>
    <description>PCNL using miniature nephroscope. The procedure will be performed under general or regional anaesthesia under fluoroscopy guidance.</description>
    <arm_group_label>mini-PNL group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RIRS</intervention_name>
    <description>RIRS using flexible ureteroscope. The procedure will be performed under general or regional anaesthesia under fluoroscopy guidance. Holmium Laser lithotripter will be used for stone fragmentation.</description>
    <arm_group_label>RIRS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SWL</intervention_name>
    <description>SWL using Dornier SII lithotripter. the procedure will be performed under sedoanalgesia, and fluoroscopy will be used for stone localization; for a maximum of 3 SWL session.</description>
    <arm_group_label>SWL group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (both genders)&#xD;
&#xD;
          -  Single non-lower pole renal stone.&#xD;
&#xD;
          -  Stone size: 10-20 mm.&#xD;
&#xD;
          -  Stone density: &gt; 1000 HU.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women.&#xD;
&#xD;
          -  Morbid obesity.&#xD;
&#xD;
          -  Severe orthopaedic deformities.&#xD;
&#xD;
          -  Co-morbidities precluding general anaesthesia or prone positioning.&#xD;
&#xD;
          -  Uncorrectable coagulation disorders.&#xD;
&#xD;
          -  Active urinary tract infection (UTI).&#xD;
&#xD;
          -  Stone in a calyceal diverticulum.&#xD;
&#xD;
          -  Abnormal renal anatomy.&#xD;
&#xD;
          -  Urinary tract obstruction distal to the stone.&#xD;
&#xD;
          -  Concomitant pathology that needs intervention in the same setting.&#xD;
&#xD;
          -  Advanced hydronephrosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Abul-fotouh Ahmed, MD</last_name>
    <phone>00201001066756</phone>
    <email>abulfotouhahmed@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology Department, Al-Azhar University Hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11633</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Fahim, MD</last_name>
      <phone>002025107333</phone>
      <email>urologyhospital@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Hassan Abdelazeim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 17, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2021</study_first_posted>
  <last_update_submitted>April 21, 2021</last_update_submitted>
  <last_update_submitted_qc>April 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Al-Azhar University</investigator_affiliation>
    <investigator_full_name>Abul-fotouh Ahmed</investigator_full_name>
    <investigator_title>Professor of Urology and Andrology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

